PFO
CORZ

Pathstone Family Office’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Pathstone Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,667,377
Closed -$1.17M – 1408
2022
Q4 		$1.17M Buy
2,667,377
+625,662
+31% +$287K 0.02% 419
2022
Q3 		$2.65M Buy
2,041,715
+2,000,380
+4,839% +$4.26M 0.05% 208
2022
Q2 		$61.6K Buy
41,335
+30,678
+288% +$141K ﹤0.01% 1012
2022
Q1 		$87K Buy
+10,657
New +$94.1K ﹤0.01% 929

Other funds holding CORZ

SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CWC
Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return
BWP
BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Pathstone Family Office's CORZ Position: Q1 2023 in Review

Pathstone Family Office sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 2,667,377 shares — an estimated $1.17M sold.

Pathstone Family Office first reported a position in CORZ in Q1 2022 and held it in 4 quarters. The position peaked at $2.65M in Q3 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

  • Pathstone Family Office reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Pathstone Family Office sold 2,667,377 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $1.17M.
  • Pathstone Family Office first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Pathstone Family Office's Core Scientific, Inc. Common Stock position peaked at $2.65M in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.